Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
crsrelapse
acute lymphoblastic leukemia, cd19 positive, relapse, refractory, cd19+ ,car-t, crs, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 912585
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.